MedTrace Logo

MEMENTO-VAScular COmponents of Dementia

NCT02264899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 332

Last updated 2022-01-28

No results posted yet for this study

Summary

A Multicenter national longitudinal cohort study including at least 800 individuals recruited from French Research Memory Centers and followed up over 36 months and included in Memento.

Conditions

  • Alzheimer's Disease (AD)
  • Alzheimer's Disease (AD) Related Disorders

Interventions

OTHER

in Memento-VASCOD

* Pulse wave velocity assessment * Cerebral MRI including Arterial Spin Labeling (ASL) and Magnetic Resonance Angiography (MRA) sequences * Ophthalmological exams: Spectral Domain-Optical Coherence Tomography (SD-OCT), colour photographs of the retina, visual acuity and axial lenght measurement * Neuropsychological testing and behaviorial and mood scales * Urinary albumin excretion measurement

Sponsors & Collaborators

  • Ministry for Health and Solidarity, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Genevieve CHENE, Prof · CIC-EC1401 - ISPED - CHU de Bodeaux

  • Geneviève CHENE, Prof · CIC-EC1401 - ISPED - CHU de Bordeaux

  • Carole DUFOUIL, Director · CIC-EC1401 - ISPED - CHU de Bordeaux

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-04
Primary Completion
2021-10-29
Completion
2021-10-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264899 on ClinicalTrials.gov